These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33127342)

  • 1. SETD8 promotes stemness characteristics and is a potential prognostic biomarker of gastric adenocarcinoma.
    Piao L; Che N; Li H; Li M; Feng Y; Liu X; Kim S; Jin Y; Xuan Y
    Exp Mol Pathol; 2020 Dec; 117():104560. PubMed ID: 33127342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
    Li H; Piao L; Xu D; Xuan Y
    Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SETD8 is a prognostic biomarker that contributes to stem-like cell properties in non-small cell lung cancer.
    Piao L; Feng Y; Che N; Li M; Li X; Jin Y; Xuan Y
    Pathol Res Pract; 2020 Dec; 216(12):153258. PubMed ID: 33130499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gli1 regulates stemness characteristics in gastric adenocarcinoma.
    Qi W; Yang Z; Feng Y; Li H; Che N; Liu L; Xuan Y
    Diagn Pathol; 2020 May; 15(1):60. PubMed ID: 32430068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma.
    Piao L; Feng Y; Yang Z; Qi W; Li H; Han H; Xuan Y
    Pathol Res Pract; 2019 Jul; 215(7):152437. PubMed ID: 31101574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma.
    Yang Z; Zhang C; Qi W; Cui Y; Xuan Y
    Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notum enhances gastric cancer stem-like cell properties through upregulation of Sox2 by PI3K/AKT signaling pathway.
    Liu Y; Chen H; Xiao L; Dong P; Ma Y; Zhou Y; Yang J; Bian B; Xie G; Chen L; Shen L
    Cell Oncol (Dordr); 2024 Apr; 47(2):463-480. PubMed ID: 37749430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma.
    Cui Y; Cui CA; Yang ZT; Ni WD; Jin Y; Xuan YH
    Exp Mol Pathol; 2017 Apr; 102(2):347-353. PubMed ID: 28286162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.
    Bie Q; Sun C; Gong A; Li C; Su Z; Zheng D; Ji X; Wu Y; Guo Q; Wang S; Xu H
    Sci Rep; 2016 May; 6():25447. PubMed ID: 27146881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression.
    Liu M; Shi Y; Hu Q; Qin Y; Ji S; Liu W; Zhuo Q; Fan G; Ye Z; Song C; Yu X; Xu X; Xu W
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1614-1624. PubMed ID: 34599596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
    Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
    Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer.
    Wada M; Kukita A; Sone K; Hamamoto R; Kaneko S; Komatsu M; Takahashi Y; Inoue F; Kojima M; Honjoh H; Taguchi A; Kashiyama T; Miyamoto Y; Tanikawa M; Tsuruga T; Mori-Uchino M; Wada-Hiraike O; Osuga Y; Fujii T
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer.
    Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ
    Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.
    Lu J; Bang H; Kim SM; Cho SJ; Ashktorab H; Smoot DT; Zheng CH; Ryeom SW; Yoon SS; Yoon C; Lee JH
    Oncogene; 2021 Feb; 40(5):922-936. PubMed ID: 33288885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric Adenocarcinoma Biomarker Expression Profiles and their Prognostic Value.
    Senol S; Aydin A; Kosemetin D; Ece D; Akalin I; Abuoglu H; Duran EA; Aydin D; Erkol B
    J Environ Pathol Toxicol Oncol; 2016; 35(3):207-222. PubMed ID: 27910777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
    Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability.
    Xiao Y; Pan J; Geng Q; Wang G
    FEBS Open Bio; 2019 Jul; 9(7):1212-1222. PubMed ID: 31037832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
    Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
    Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC.
    Li X; Liu Z; Xia C; Yan K; Fang Z; Fan Y
    Cancer Lett; 2022 Feb; 527():150-163. PubMed ID: 34942305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.